Induction therapy with high‐dose fluconazole plus flucytosine for human immunodeficiency virus‐uninfected cryptococcal meningitis patients: Feasible or not?

BACKGROUND: Cryptococcal meningitis (CM) is increasingly recognised in human immunodeficiency virus (HIV)‐uninfected patients with high mortality. The efficacy and safety profiles of induction therapy with high‐dose fluconazole plus flucytosine remain unclear. METHODS: HIV‐uninfected CM patients who...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Hua‐Zhen, Cheng, Jia‐Hui, Zhou, Ling‐Hong, Luo, Yu, Zhu, Rong‐Sheng, Jiang, Ying‐Kui, Wang, Xuan, Zhu, Li‐Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087831/
https://www.ncbi.nlm.nih.gov/pubmed/36111370
http://dx.doi.org/10.1111/myc.13528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087831/
https://www.ncbi.nlm.nih.gov/pubmed/36111370
http://dx.doi.org/10.1111/myc.13528

Ejemplares similares